Loading…
Legislative Progress
Introduced
February 14, 2017
Latest Action
February 14, 2017
Primary Sponsor
Gus M. BilirakisRepublican(FL)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 7,393 other HR bills in the 115th — cohort avg 50d
Stop Handouts to Unauthorized Taxpayers Act of 2017 or the SHUT Act of 201 7 This bill amends the Internal Revenue Code to deny the refundable portion of the child tax credit to individuals unless they include their Social Security number on their tax return or otherwise demonstrate that they are authorized to be employed in the United States. The bill prohibits the Department of the Treasury or any delegate of Treasury from issuing an individual taxpayer identification number unless the supporting documentary evidence is submitted to a Treasury employee.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2018 · fourth_quarter · Health Issues
Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable care Act (HR 3590/PL 111-148); Health Care and Education Reconciliation Act (HR 4872/PL 111-152); the Protect Medical Innovation Act (HR 1041/S108); the implementation of the medicare Access and CHIP reauthorization Act (HR 2); diabetic retinopathy; Bipartisan Budget Act of 2018; safe patient handling,FDA reform;Extension of Continuing Appropriations Act of 2018; H.R. 6639 Diabetic Retinopathy Vision Loss and Blindness Prevention Act, Medical Device Tax Repeal (HR 184)
Referred to the House Committee on Ways and Means.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $220,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2018 · fourth_quarter · Medicare/Medicaid
Diabetic Eye Disease Prevention Act (H.R. 4642). Safe Patient Handling, FDA Reform, Technology research. Implementation of Patient Protection and Affordable care Act (HR 3590/PL 111-148); Health Care and Education Reconciliation Act (HR 4872/PL 111-152); the Protect Medical Innovation Act (HR 1041/S108); the implementation of the medicare Access and CHIP reauthorization Act (HR 2); Diabetic RetinopathyVision Loss and Blindness Prevention Act of 2018; Bipartisan Budget Act of 2018; safe patient handling,FDA reform;Extension of continuing Appropriations; Medical Device Tax Repeal (HR 184)
Client expense: $220,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2018 · third_quarter · Health Issues
Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the Protect Medical Innovation Act (H.R. 1041/S. 108); the implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); diabetic retinopathy; Bipartisan Budget Act of 2018; safe patient handling, FDA reform; Extension of Continuing Appropriations Act of 2018; H.R.6639 Diabetic Retinopothy Vision Loss and Blindness Prevention Act of 2018
Client expense: Not reported · Firm income: $250,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2018 · third_quarter · Medicare/Medicaid
Diabetic Eye Disease Prevention Act (H.R. 4642). Safe Patient Handling, FDA Reform, Technology research. Implementation of Patient Protection and Affordable care Act (HR 3590/PL 111-148); Health Care and Education Reconciliation Act (HR 4872/PL 111-152); the Protect Medical Innovation Act (HR 1041/S108); the implementation of the medicare Access and CHIP reauthorization Act (HR 2); diabetic retinopathy; Bipartisan Budget Act of 2018; safe patient handling,FDA reform;Extension of continuing Appropriations; Medical Device Tax Repeal (HR 184)
Client expense: $380,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE
2018 · third_quarter · Health Issues
Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable care Act (HR 3590/PL 111-148); Health Care and Education Reconciliation Act (HR 4872/PL 111-152); the Protect Medical Innovation Act (HR 1041/S108); the implementation of the medicare Access and CHIP reauthorization Act (HR 2); diabetic retinopathy; Bipartisan Budget Act of 2018; safe patient handling,FDA reform;Extension of Continuing Appropriations Act of 2018; H.R. 6639 Diabetic Retinopathy Vision Loss and Blindness Prevention Act, Medical Device Tax Repeal (HR 184)
Client expense: $380,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE
2018 · second_quarter · Health Issues
Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the Protect Medical Innovation Act (H.R. 1041/S. 108); the implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); diabetic retinopathy; Bipartisan Budget Act of 2018; safe patient handling, FDA reform; Extension of Continuing Appropriations Act of 2018.
Client expense: Not reported · Firm income: $130,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2018 · second_quarter · Health Issues
Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable care Act (HR 3590/PL 111-148); Health Care and Education Reconciliation Act (HR 4872/PL 111-152); the Protect Medical Innovation Act (HR 1041/S108); the implementation of the medicare Access and CHIP reauthorization Act (HR 2); diabetic retinopathy; Bipartisan Budget Act of 2018; safe patient handling,FDA reform;Extension of continuing Appropriations; Medical Device Tax Repeal (HR 184)
Client expense: $205,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE
2018 · second_quarter · Medicare/Medicaid
Diabetic Eye Disease Prevention Act (H.R. 4642). Safe Patient Handling, FDA Reform, Technology research. Implementation of Patient Protection and Affordable care Act (HR 3590/PL 111-148); Health Care and Education Reconciliation Act (HR 4872/PL 111-152); the Protect Medical Innovation Act (HR 1041/S108); the implementation of the medicare Access and CHIP reauthorization Act (HR 2); diabetic retinopathy; Bipartisan Budget Act of 2018; safe patient handling,FDA reform;Extension of continuing Appropriations; Medical Device Tax Repeal (HR 184)
Client expense: $205,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE
2018 · first_quarter · Health Issues
Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the Protect Medical Innovation Act (H.R. 1041/S. 108); the implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); diabetic retinopathy; Bipartisan Budget Act of 2018; safe patient handling, FDA reform; Extension of Continuing Appropriations Act of 2018.
Client expense: Not reported · Firm income: $130,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2018 · first_quarter · Health Issues
Health Care Reform Implementation & Taxation of Medical Technology Devices e.g. (Patient Protection and Affordable Care Act (H.R. 3590/P.L. 11-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152), the Protect Medical Innovation Act (H.R. 1041/S.108); The Medicare Access and CHIP Reauthorization Act (H.R. 2). Telemedicine and connected care; remote patient monitoring including: Medicare Telehealth Parity Act (H.R. 2948); CONNECT for Health Act (S. 2484/HR 4442); Diabetic Eye Disease Prevention Act (H.R. 4642). Safe Patient Handling, FDA Reform, Technology research.
Client expense: $220,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE, Vice President of the U.S.
2017 · fourth_quarter · Health Issues
Health Care Reform Implementation & Taxation of Medical Technology Devices e.g. (Patient Protection and Affordable Care Act (H.R. 3590/P.L. 11-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152), the Protect Medical Innovation Act (H.R. 1041/S.108); The Medicare Access and CHIP Reauthorization Act (H.R. 2). Telemedicine and connected care; remote patient monitoring including: Medicare Telehealth Parity Act (H.R. 2948); CONNECT for Health Act (S. 2484/HR 4442); Diabetic Eye Disease Prevention Act (H.R. 4642). Safe Patient Handling, FDA Reform, Technology research.
Client expense: $150,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, SENATE, Vice President of the U.S., White House Office
2017 · fourth_quarter · Health Issues
Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the Protect Medical Innovation Act (H.R. 1041/S. 108); the implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); diabetic retinopathy; the American Health Care Act (H.R. 1628)/Better Care Reconciliation Act; safe patient handling, FDA reform.
Client expense: Not reported · Firm income: $90,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2017 · third_quarter · Health Issues
Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the Protect Medical Innovation Act (H.R. 1041/S. 108); the implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); diabetic retinopathy; the American Health Care Act (H.R. 1628)/Better Care Reconciliation Act; safe patient handling, FDA reform.
Client expense: Not reported · Firm income: $70,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2017 · second_quarter · Health Issues
Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the Protect Medical Innovation Act (H.R. 1041/S. 108); the implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); diabetic retinopathy; the American Health Care Act (H.R. 1628); safe patient handling, FDA reform.
Client expense: Not reported · Firm income: $70,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2017 · first_quarter · Health Issues
Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the Protect Medical Innovation Act (H.R. 1041/S. 108); the implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); diabetic retinopathy; the American Health Care Act (H.R. 1628); safe patient handling, FDA reform.
Client expense: Not reported · Firm income: $70,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE